North America RNA Analysis Market Size, Share & Industry Trends Analysis Report By Product, By Technology (Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology), By End-use, By Application, By Country and Growth Forecast, 2022 – 2028
The North America RNA Analysis Market would witness market growth of 15.1% CAGR during the forecast period (2022-2028).
A cell's identity is determined by the transcription of a subset of its genes into complementary RNA molecules, which also controls the biological processes taking place inside the cell. These are crucial for deciphering the functional components of the genome and comprehending development and illness. The transcriptome is extremely complicated and contains several coding and non-coding RNA species. Historically, according to the fundamental tenet of molecular biology, RNA molecules were considered to be merely an intermediary between genes and proteins.
Because they used the genetic code to encode proteins, messenger RNA molecules were the most widely investigated RNA species. There is a wide variety of noncoding RNA molecules that are functional in addition to protein-coding mRNA. Most ncRNAs were previously thought to perform fundamental cellular tasks, such as those carried out by ribosomal and transfer RNAs in mRNA translation, small nuclear RNAs in splicing, and small nucleolar RNAs that modify rRNAs.
Currently, healthcare providers are seeking ways to streamline their processes, especially concerning planning and invoicing for virtual treatment. As the use, transmission, and availability of digital health information increases, providers are required to implement stronger and more sophisticated cybersecurity measures and encryption to protect patient privacy. A significant market may exist for platforms that connect to Prescribe IT, Canada's national e-prescription system. The prevalence of chronic diseases and the aging of the population are increasing demand in the Canadian healthcare sector.
The US market dominated the North America RNA Analysis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,226.8 million by 2028. The Canada market is poised to grow at a CAGR of 17.7% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 16.7% during (2022 - 2028).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology and Others. Based on End-use, the market is segmented into Government Institutes & Academic Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROs). Based on Application, the market is segmented into Infectious Diseases & Pathogenesis, Epigenetics, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics, Construction of RNA Expression Atlas, Alternative RNA Splicing and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.
Scope of the Study
Market Segments covered in the Report:
By Product
- Kits & Reagents
- Instruments
- Services
- Real Time-PCR (qPCR) Technology
- Sequencing Technology
- Microarray Technology
- Others
- Government Institutes & Academic Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Infectious Diseases & Pathogenesis
- Epigenetics
- RNA Structure & Molecular Dynamics
- Development & Delivery of RNA Therapeutics
- Construction of RNA Expression Atlas
- Alternative RNA Splicing
- Others
- US
- Canada
- Mexico
- Rest of North America
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific Group
- Merck Group
- Promega Corporation
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America RNA Analysis Market, by Product
- 1.4.2 North America RNA Analysis Market, by Technology
- 1.4.3 North America RNA Analysis Market, by End-use
- 1.4.4 North America RNA Analysis Market, by Application
- 1.4.5 North America RNA Analysis Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition & scenarios
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Geographical Expansions
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
- Chapter 4. North America RNA Analysis Market by Product
- 4.1 North America Kits & Reagents Market by Country
- 4.2 North America Instruments Market by Country
- 4.3 North America Services Market by Country
- Chapter 5. North America RNA Analysis Market by Technology
- 5.1 North America Real Time-PCR (qPCR) Technology Market by Country
- 5.2 North America Sequencing Technology Market by Country
- 5.3 North America Microarray Technology Market by Country
- 5.4 North America Others Market by Country
- Chapter 6. North America RNA Analysis Market by End-use
- 6.1 North America Government Institutes & Academic Centers Market by Country
- 6.2 North America Hospitals & Clinics Market by Country
- 6.3 North America Pharmaceutical & Biotechnology Companies Market by Country
- 6.4 North America Contract Research Organizations (CROs) Market by Country
- Chapter 7. North America RNA Analysis Market by Application
- 7.1 North America Infectious Diseases & Pathogenesis Market by Country
- 7.2 North America Epigenetics Market by Country
- 7.3 North America RNA Structure & Molecular Dynamics Market by Country
- 7.4 North America Development & Delivery of RNA Therapeutics Market by Country
- 7.5 North America Construction of RNA Expression Atlas Market by Country
- 7.6 North America Alternative RNA Splicing Market by Country
- 7.7 North America Others Market by Country
- Chapter 8. North America RNA Analysis Market by Country
- 8.1 US RNA Analysis Market
- 8.1.1 US RNA Analysis Market by Product
- 8.1.2 US RNA Analysis Market by Technology
- 8.1.3 US RNA Analysis Market by End-use
- 8.1.4 US RNA Analysis Market by Application
- 8.2 Canada RNA Analysis Market
- 8.2.1 Canada RNA Analysis Market by Product
- 8.2.2 Canada RNA Analysis Market by Technology
- 8.2.3 Canada RNA Analysis Market by End-use
- 8.2.4 Canada RNA Analysis Market by Application
- 8.3 Mexico RNA Analysis Market
- 8.3.1 Mexico RNA Analysis Market by Product
- 8.3.2 Mexico RNA Analysis Market by Technology
- 8.3.3 Mexico RNA Analysis Market by End-use
- 8.3.4 Mexico RNA Analysis Market by Application
- 8.4 Rest of North America RNA Analysis Market
- 8.4.1 Rest of North America RNA Analysis Market by Product
- 8.4.2 Rest of North America RNA Analysis Market by Technology
- 8.4.3 Rest of North America RNA Analysis Market by End-use
- 8.4.4 Rest of North America RNA Analysis Market by Application
- Chapter 9. Company Profiles
- 9.1 F. Hoffmann-La Roche Ltd.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Acquisition and Mergers:
- 9.2 Danaher Corporation
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Acquisition and Mergers:
- 9.3 Agilent Technologies, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.5.2 Product Launches and Product Expansions:
- 9.3.5.3 Acquisition and Mergers:
- 9.4 Thermo Fisher Scientific, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.5.2 Product Launches and Product Expansions:
- 9.4.5.3 Acquisition and Mergers:
- 9.5 Qiagen N.V.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.5.2 Product Launches and Product Expansions:
- 9.6 Illumina, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.5.2 Product Launches and Product Expansions:
- 9.6.5.3 Acquisition and Mergers:
- 9.7 Bio-Rad laboratories, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Product Launches and Product Expansions:
- 9.8 Eurofins Scientific Group
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Recent strategies and developments:
- 9.8.4.1 Product Launches and Product Expansions:
- 9.9 Merck Group
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.5.2 Acquisition and Mergers:
- 9.10. Promega Corporation
- 9.10.1 Company Overview
- 9.10.2 Recent strategies and developments:
- 9.10.2.1 Product Launches and Product Expansions:
- 9.10.2.2 Geographical Expansions:
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook